This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Aetna enters agreement to sell entire standalone Medicare Part D business to WellCare

( September 27, 2018, 17:11 GMT | Official Statement) -- MLex Summary: Aetna on Wednesday entered an agreement with a WellCare Health Plans subsidiary to divest its entire standalone Medicare Part D prescription drug plan business, CVS said in a securities filing Thursday. The close of the divestiture is conditioned on the closing of CVS Health's proposed transaction with Aetna and subject to regulatory approvals. CVS said it believes the divestiture "is a significant step toward completing the [US Department of Justice's] review of the CVS Health Transaction. CVS Health and Aetna continue to engage in productive discussions with the DOJ." CVS said it continues to expect the deal to close in the "early part of the fourth quarter."Excerpt....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login